FERROLA 37mg / 0.8mg gastro-resistant tablets medication leaflet

B03AD03 iron sulfate + folic acid • Blood and blood forming organs | Iron preparations | Iron in combination with folic acid


The combination of ferrous sulfate and folic acid is used to prevent and treat anemia, especially in pregnant women or people with iron and folic acid deficiency. Ferrous sulfate provides the iron needed for hemoglobin formation, while folic acid helps produce healthy red blood cells.

This medication is usually taken as tablets, as prescribed by your doctor. It is important to follow the recommended dose and not to stop treatment without your doctor's approval to ensure the therapy's effectiveness.

Common side effects include nausea, stomach discomfort, constipation, or dark-colored stools. In rare cases, allergic reactions or severe digestive disorders may occur. If you experience any unusual or severe symptoms, contact your doctor immediately.

The combination of ferrous sulfate and folic acid is essential for preventing anemia complications, especially during pregnancy. Inform your doctor about any other medications or supplements you are taking to avoid interactions.

General data about FERROLA 37mg / 0.8mg

Substance: iron sulfate + folic acid

Date of last drug list: 01-03-2022

Commercial code: W63335001

Concentration: 37mg / 0.8mg

Pharmaceutical form: gastro-resistant tablets

Quantity: 30

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: LOMAPHARM RUDOLF LOHMANN GMBH KG - GERMANIA

Holder: WÖRWAG PHARMA GMBH & CO. KG - GERMANIA

Number: 6777/2014/01

Shelf life: 5 years

Pharmaceutical forms available for iron sulfate + folic acid

Concentrations available for iron sulfate + folic acid

37mg/0.8mg, 80mg/0.350mg

Combinations with other substances